Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Etienne G C Brain

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Anti-Cancer Drugs|August 14, 2002
Safety and efficacy of ET-743: the French experienceEtienne G C Brain
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 12, 2023
Systemic Therapy in Older Patients With High-Risk DiseaseEtienne G C Brain
Current Opinion in Oncology|October 15, 2005
Adjuvant chemotherapy in elderly patients with breast cancer: where are we?Hans Wildiers, Etienne G C Brain
British Journal of Clinical Pharmacology|February 26, 2008
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules: an n = 1 randomized studyEtienne G C Brain, Kevan Rezai, François Lokiec, et al.
Bulletin Du Cancer|December 17, 2008
[Breast cancer in the elderly]Maya Gutierrez, Fatma Ben Abid, Amale Ousbane, et al.
JAMA|May 19, 2005
Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancerEtienne G C Brain, Thomas Bachelot, Daniel Serin, et al.
Critical Reviews in Oncology/Hematology|November 2, 2010
Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trialEtienne G C Brain, Cécile Mertens, Véronique Girre, et al.
NPJ Breast Cancer|November 3, 2024
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancersFlorentine S Hilbers, Coralie Poncet, Konstantinos Tryfonidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX StudyNicolas Penel, Binh Nguyen Bui, Jacques-Olivier Bay, et al.
The Lancet. Oncology|May 17, 2021
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)Laura Biganzoli, Nicolò Matteo Luca Battisti, Hans Wildiers, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Anti-Cancer Drugs|August 14, 2002
Safety and efficacy of ET-743: the French experienceEtienne G C Brain
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 12, 2023
Systemic Therapy in Older Patients With High-Risk DiseaseEtienne G C Brain
Current Opinion in Oncology|October 15, 2005
Adjuvant chemotherapy in elderly patients with breast cancer: where are we?Hans Wildiers, Etienne G C Brain
British Journal of Clinical Pharmacology|February 26, 2008
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules: an n = 1 randomized studyEtienne G C Brain, Kevan Rezai, François Lokiec, et al.
Bulletin Du Cancer|December 17, 2008
[Breast cancer in the elderly]Maya Gutierrez, Fatma Ben Abid, Amale Ousbane, et al.
JAMA|May 19, 2005
Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancerEtienne G C Brain, Thomas Bachelot, Daniel Serin, et al.
Critical Reviews in Oncology/Hematology|November 2, 2010
Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trialEtienne G C Brain, Cécile Mertens, Véronique Girre, et al.
NPJ Breast Cancer|November 3, 2024
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancersFlorentine S Hilbers, Coralie Poncet, Konstantinos Tryfonidis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX StudyNicolas Penel, Binh Nguyen Bui, Jacques-Olivier Bay, et al.
The Lancet. Oncology|May 17, 2021
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)Laura Biganzoli, Nicolò Matteo Luca Battisti, Hans Wildiers, et al.
Pageof 2